Humacyte Historical Income Statement
| HUMAW Stock | USD 1.50 0.09 5.66% |
Historical analysis of Humacyte income statement accounts such as Selling General Administrative of 21.1 M or Total Revenue of 0.0 can show how well Humacyte performed in making a profits. Evaluating Humacyte income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Humacyte's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Humacyte latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Humacyte is a good buy for the upcoming year.
Humacyte |
About Humacyte Income Statement Analysis
Humacyte Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Humacyte shareholders. The income statement also shows Humacyte investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Humacyte Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Humacyte. It is also known as Humacyte overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Humacyte income statement and represents the costs associated with goods and services Humacyte provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Humacyte's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Humacyte current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humacyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.At this time, Humacyte's Depreciation And Amortization is fairly stable compared to the past year. Cost Of Revenue is likely to climb to about 80.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 21.1 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 4.3M | 6.2M | 1.1M | 1.1M | Depreciation And Amortization | 8.3M | 8.3M | 7.7M | 8.7M |
Humacyte income statement Correlations
Click cells to compare fundamentals
Humacyte Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Humacyte Stock Analysis
When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.